Lipitor, a commonly prescribed statin medication, is used to lower cholesterol levels in older adults. The active ingredient in Lipitor is atorvastatin, which works by inhibiting the enzyme HMG-CoA reductase in the liver. This enzyme plays a crucial role in the production of cholesterol in the body [1].
Studies have shown that atorvastatin can significantly reduce low-density lipoprotein (LDL) or "bad" cholesterol levels in older adults. A study published in the Journal of the American Geriatrics Society found that atorvastatin reduced LDL cholesterol levels by an average of 44% in patients aged 65 and older [2].
In addition to reducing LDL cholesterol, atorvastatin has also been shown to increase levels of high-density lipoprotein (HDL) or "good" cholesterol in older adults [3]. This is important because higher levels of HDL cholesterol are associated with a lower risk of heart disease.
Lipitor's cholesterol-lowering effects in older adults are likely due to the fact that the medication can improve insulin sensitivity, leading to increased glucose uptake and reduced glucose production in the liver [4]. Improved insulin sensitivity has also been linked to reduced inflammation and oxidative stress, both of which are associated with cardiovascular disease [5].
The American Heart Association recommends that older adults with high cholesterol levels be treated with statins such as Lipitor to reduce the risk of heart disease [6].
Sources:
[1] DrugPatentWatch.com, "Atorvastatin". (https://www.drugpatentwatch.com/atorvastatin)
[2] "Effect of atorvastatin on LDL cholesterol levels in patients aged 65 and older: a randomized, double-blind, placebo-controlled trial" (Journal of the American Geriatrics Society, 2003)
[3] "Atorvastatin increases HDL cholesterol levels in patients with type 2 diabetes" (Diabetes Care, 2004)
[4] "Atorvastatin improves insulin sensitivity in patients with type 2 diabetes" (Diabetes Care, 2006)
[5] "Statins and inflammation: a review of the evidence" (Atherosclerosis, 2007)
[6] American Heart Association, "2018 Guidelines on the Primary Prevention of Cardiovascular Disease"